Federated Hermes’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-430
| Closed | -$14.3K | – | 2324 |
|
|
2022
Q4 | $14.3K | Buy |
430
+125
| +41% | +$4.03K | ﹤0.01% | 1832 |
|
|
2022
Q3 | $10K | Buy |
305
+108
| +55% | +$3.5K | ﹤0.01% | 1838 |
|
|
2022
Q2 | $6K | Sell |
197
-160
| -45% | -$4.33K | ﹤0.01% | 1889 |
|
|
2022
Q1 | $9K | Hold |
357
| – | – | ﹤0.01% | 1904 |
|
|
2021
Q4 | $7K | Sell |
357
-454
| -56% | -$8.71K | ﹤0.01% | 1974 |
|
|
2021
Q3 | $16K | Sell |
811
-6
| -0.7% | -$120 | ﹤0.01% | 1950 |
|
|
2021
Q2 | $18K | Sell |
817
-224
| -22% | -$4.75K | ﹤0.01% | 1936 |
|
|
2021
Q1 | $27K | Buy |
+1,041
| New | +$24.8K | ﹤0.01% | 1930 |
|
|
2020
Q3 | – | Sell |
-155
| Closed | -$4K | – | 2383 |
|
|
2020
Q2 | $4K | Buy |
+155
| New | +$2.25K | ﹤0.01% | 2030 |
|
|
2019
Q4 | – | Sell |
-18,067
| Closed | -$171K | – | 2337 |
|
|
2019
Q3 | $171K | Buy |
+18,067
| New | +$190K | ﹤0.01% | 1603 |
|
|
2019
Q1 | – | Sell |
-102
| Closed | -$2K | – | 2251 |
|
|
2018
Q4 | $2K | Buy |
+102
| New | +$1.74K | ﹤0.01% | 2098 |
|
|
2018
Q3 | – | Sell |
-489
| Closed | -$8K | – | 2358 |
|
|
2018
Q2 | $8K | Buy |
+489
| New | +$7.29K | ﹤0.01% | 1947 |
|
|
2013
Q3 | – | Sell |
-131,580
| Closed | -$2.83M | – | 1787 |
|
|
2013
Q2 | $2.83M | Buy |
+131,580
| New | +$2.84M | 0.01% | 757 |
|
Other funds holding VIVO
Federated Hermes's VIVO Position: Q1 2023 in Review
Federated Hermes sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 430 shares — an estimated $14.3K sold.
Federated Hermes first reported a position in VIVO in Q2 2013 and held it in 13 quarters. The position peaked at $2.83M in Q2 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Federated Hermes reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Federated Hermes sold 430 Meridian Bioscience Inc shares in Q1 2023, an estimated $14.3K.
- Federated Hermes first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 13 quarters.
- Federated Hermes's Meridian Bioscience Inc position peaked at $2.83M in Q2 2013.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.